Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.
about
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors.ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
P2860
Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@en
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@nl
type
label
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@en
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@nl
prefLabel
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@en
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@nl
P2093
P2860
P1433
P1476
Evaluation of Concurrent Radia ...... ered Glioblastoma Mouse Model.
@en
P2093
Alnawaz Rehemtulla
Brian D Ross
Christina Tsein
Craig J Galbán
Eric C Holland
Hanxiao Wang
Kevin A Heist
Stefanie Galbán
Yinghua Li
P2860
P356
10.1016/J.NEO.2015.11.014
P577
2016-02-01T00:00:00Z